Oxycodone

Members of the Sackler family agreed to pay $6 billion to US states and local governments for their role in the opioid crisis. The Sacklers own Purdue Pharma, which manufactures the blockbuster opioid drug OxyContin. As part of the deal, family members will give up the company, which will be turned into…

As part of the settlement deal, the Sackler family must give up control of Stamford, Conn.-based Purdue -- which will be turned into a different company that will fight opioid abuse. File Photo by Justin Lane/EPA-EFE March 3 (UPI) -- The Sackler family and their company Purdue Pharma agreed to a…

Members of the Sackler family who own Purdue Pharma have reached a deal with U.S. states to pay as much as $6 billion in cash to end widespread litigation against the OxyContin maker over its role in the nation's opioid epidemic. Why it matters: The deal, which was announced on…

OxyContin maker Purdue Pharma reached a settlement Thursday over its role in the deadly opioid crisis that includes states and thousands of local governments.  The deal follows an earlier settlement that was appealed by eight states and Washington D.C. They agreed to sign on after the Sackler family – who…

The owners of Purdue Pharma, maker of OxyContin, have offered to pay up to $6 billion to victims of the US opioid crisis to settle an avalanche of litigation, according to a report filed Friday by a federal mediator. The Sackler family's new offer would raise by at least a…

Members of the Sackler family who own OxyContin maker Purdue Pharma are willing to kick in more money — up to $6 billion total — to settle thousands of lawsuits over the toll of opioids as the company tries to work out a deal with state attorneys general who torpedoed…

NPR’s sites use cookies, similar tracking and storage technologies, and information about the device you use to access our sites (together, “cookies”) to enhance your viewing, listening and user experience, personalize content, personalize messages from NPR’s sponsors, provide social media features, and analyze NPR’s traffic. This information is shared with…

Choose your subscription Trial Try full digital access and see why over 1 million readers subscribe to the FT For 4 weeks receive unlimited Premium digital access to the FT's trusted, award-winning business news Digital Be informed with the essential news and opinion MyFT – track the topics most important…

Author of the article: Reuters Tom Hals and Dietrich Knauth Purdue Pharma will ask a bankruptcy judge on Thursday to extend a legal shield that prevents opioid lawsuits from going forward against some members of the wealthy Sackler family who own the OxyContin maker. The hearing before Judge Robert Drain…

This advertisement has not loaded yet, but your article continues below. Author of the article: Article content A mediator holding talks between members of the Sackler family that own Purdue Pharma and U.S. states opposed to the OxyContin-maker’s bankruptcy exit plan requested an extension of the mediation deadline to Feb.…